$68.37 $2.27 per serving
Product analysis
TransMax TR keeps the formula focused on resveratrol. Missing extract composition details make it harder to judge what the declared amount delivers.
AI assessment of the formula, label and price. How scoring works
Nutrient Quality40
The source is identified as trans-resveratrol from a plant extract. That identity alone does not establish preparation quality or absorption.
Ingredient Transparency80
The declared amount and source can be compared. Missing extract composition leaves the concentration unclear.
Value For Money40
Value relative to the trans-resveratrol contribution remains uncertain. The amount and cost details needed for that comparison are incomplete.
Customer Satisfaction68
Buyer ratings are generally positive. The more modest number of ratings gives a narrower picture of satisfaction.
Product Focus61
Resveratrol is the sole active focus across several intended uses. The simple composition avoids the added complexity of a wider blend.
- Format
Capsule - Container
- 60 Capsule(s)
- Per serving
- $2.27
- Customer rating
- 4.5 · 135 ratings
Goals
Impact
Moderate effect
TransMax TR provides 500 mg trans-resveratrol from Polygonum cuspidatum root extract as its only credited ingredient. The saved comparison links it to endothelial nitric-oxide function, but that pathway remains below its breadth threshold and other pathways show none. Its evidence ceiling is limited relative to the cardiovascular goal’s highest ceiling.
How this product is rated for Cardiovascular Support
Ingredient fit94
Resveratrol is the sole credited ingredient, with no actives tied to other goals. Its declared amount meets the dose reference.
Goal fit
Resveratrol is the sole credited ingredient, with no off-goal actives listed.
Dose adequacy
The 500 mg serving amount meets the comparison’s dose threshold.
Pathways17
Endothelial nitric-oxide function is the only covered pathway, with partial coverage.
Depth
Endothelial nitric-oxide function is the only covered pathway, with partial coverage.
Breadth
No pathway reaches the breadth threshold because endothelial coverage remains below half.
Evidence55
Resveratrol has the formula’s highest credited evidence ceiling, which is below the goal’s highest ceiling.
Evidence strength
Resveratrol has the highest evidence ceiling in the formula, below the goal’s top ceiling.
Studied preparation
The credited resveratrol preparation is represented in trials at its counted amount.
Formulation logic100
The ingredient works on its own, with no matched conflict. It meets the comparison’s dose threshold.
Partner coverage
The credited ingredient works on its own.
Conflicts
No formulation conflict is matched in the supplied facts.
Effective doses
The sole credited ingredient meets the comparison’s dose threshold.
Impact
Lower effect
Impact
Highest effect
Resveratrol · 500 mg
Impact
Highest effect
Resveratrol · 500 mg
Resveratrol has been studied in an oral skin blend, but those findings cannot establish what isolated resveratrol does for skin. The saved amount comparison does not resolve this limitation or establish a useful standalone skin dose.
How this product is rated for Skin Health
Ingredient fit94
The relevant connection is mainly nutritional support or limited surrogate evidence, rather than established cosmetic improvement.
Goal fit
The relevant connection is mainly nutritional support or limited surrogate evidence, rather than established cosmetic improvement.
Dose adequacy
The declared amounts support the saved exposure comparison; larger nutrient amounts do not establish extra benefit when intake is adequate.
Pathways56
The represented skin route has limited support from the supplied ingredients and amounts.
Depth
The represented skin route has limited support from the supplied ingredients and amounts.
Breadth
Coverage is limited to the skin routes represented by the supplied ingredients; it does not imply broad improvement.
Evidence83
Blend evidence cannot establish isolated resveratrol effects.
Evidence strength
Blend evidence cannot establish isolated resveratrol effects.
Studied preparation
The supplied preparation finding does not establish superiority of a nutrient form or equivalence to a different studied blend.
Formulation logic100
The supplied findings identify no required missing partner or specified conflict. Amount comparisons do not establish combination benefits.
Partner coverage
No missing required partner limits the eligible ingredients; no automatic combination benefit follows.
Conflicts
No specified ingredient conflict was identified in the supplied findings.
Effective doses
The included ingredients meet the supplied minimum exposure comparison; this is not a proven clinical benefit threshold.
Ingredients
| Ingredient | Amount per serving | Score |
|---|---|---|
MicroActive Resveratrol (Polygonum cuspidatum root extract, Trans-Resveratrol) | 500 mg |
The selected serving provides 490 mg of trans-resveratrol from 500 mg of material at 98% concentration, with a moderate cost for the amount of trans-resveratrol. The stated trans-resveratrol concentration is 98%. The source preparation is unspecified.
How this ingredient is rated
Composition and Label Disclosure100
The trans form is named. The stated trans-resveratrol concentration is 98%.
Explicit Label Detail
The label names the trans-resveratrol form.
Trans-Resveratrol Concentration Disclosure
The stated trans-resveratrol concentration is 98%.
Composition and Label Disclosure100
The selected serving provides 490 mg of trans-resveratrol from 500 mg of material at 98% concentration.
Resveratrol Amount Disclosure
The selected serving provides 490 mg of trans-resveratrol from 500 mg of material at 98% concentration.
Commercial Price and Usability75
The cost for the amount of trans-resveratrol is moderate.
Cost per 250 mg Declared Trans-Resveratrol
The cost for the amount of trans-resveratrol is moderate.
Alternative products
Report alternatives
Sources
Published studies used for the product analysis and the top-ranked studies for each ingredient and goal.
- Consumption of a grape extract supplement containing resveratrol decreases oxidized LDL and ApoB in patients undergoing primary prevention of cardiovascular disease: a triple-blind, 6-month follow-up, placebo-controlled, randomized trial.
- Resveratrol improves lipid profile and recovers heart function in postoperative CABG patients.
- Resveratrol Supplementation and its Potential Benefits in Obesity-related Non-communicable Diseases.
- Chronic resveratrol consumption improves brachial flow-mediated dilatation in healthy obese adults.
- Effect of resveratrol supplementation on lipid profile in subjects with dyslipidemia: A randomized double-blind, placebo-controlled trial.
- Role of resveratrol supplementation in regulation of glucose hemostasis, inflammation and oxidative stress in patients with diabetes mellitus type 2: A randomized, placebo-controlled trial.
- Resveratrol decreases local inflammatory markers and systemic endotoxin in patients with aggressive periodontitis.
- Effects of resveratrol supplementation on inflammatory markers, fatigue scale, fasting blood sugar and lipid profile in relapsing-remitting multiple sclerosis patients: a double-blind, randomized placebo-controlled trial.
- One-year consumption of a grape nutraceutical containing resveratrol improves the inflammatory and fibrinolytic status of patients in primary prevention of cardiovascular disease.
- Effects of resveratrol supplementation on risk factors of non-communicable diseases: A meta-analysis of randomized controlled trials.
- Effects of resveratrol on memory performance, hippocampal functional connectivity, and glucose metabolism in healthy older adults.
- Effects of resveratrol on memory performance, hippocampus connectivity and microstructure in older adults - A randomized controlled trial.
- Resveratrol levels and all-cause mortality in older community-dwelling adults.
- Impact of Resveratrol Supplementation on Human Sirtuin 1: A Grading of Recommendations Assessment, Development and Evaluation-Assessed Systematic Review and Dose-Response Meta-Analysis of Randomized Controlled Trials.
- Trans-resveratrol reduces visible signs of skin ageing in healthy adult females over 40: an 8-week randomized placebo-controlled trial.
- Effects of resveratrol on glucose control and insulin sensitivity in subjects with type 2 diabetes: systematic review and meta-analysis.
- Effects of resveratrol supplementation on multiple health outcomes: an umbrella review of systematic reviews and meta-analyses of randomized controlled trials.
- Resveratrol improves insulin resistance, glucose and lipid metabolism in patients with non-alcoholic fatty liver disease: a randomized controlled trial.
- Supplementation with resveratrol modified gut microbiota improving insulin sensitivity and lipid metabolism in subjects with obesity and insulin resistance.
- Efficacy of Resveratrol Supplementation on Glucose and Lipid Metabolism: A Meta-Analysis and Systematic Review.